Christos Thomadakis, Ilias Gountas, Erika Duffell, Konstantinos Gountas, Benjamin Bluemel, Thomas Seyler, Filippo Maria Pericoli, Irene Kászoni-Rückerl, Ziad El-Khatib, Martin Busch, Irene Schmutterer, Thomas Vanwolleghem, Sofieke Klamer, Els Plettinckx, Laure Mortgat, Dominique Van Beckhoven, Tonka Varleva, Mirjana Lana Kosanovic Licina, Tatjana Nemeth Blazic, Diana Nonković, Fanitsa Theophanous, Vratislav Nemecek, Marek Maly, Peer Brehm Christensen, Susan Cowan, Kristi Rüütel, Henrikki Brummer-Korvenkontio, Cécile Brouard, Gyde Steffen, Amrei Krings, Sandra Dudareva, Ruth Zimmermann, Georgia Nikolopoulou, Zsuzsanna Molnár, Emese Kozma, Magnús Gottfredsson, Niamh Murphy, Loreta A Kondili, Maria Elena Tosti, Anna Rita Ciccaglione, Barbara Suligoi, Raina Nikiforova, Renate Putnina, Ligita Jancoriene, Carole Seguin-Devaux, Tanya Melillo, Anders Boyd, Marc van der Valk, Eline Op de Coul, Robert Whittaker, Hilde Kløvstad, Małgorzata Stępień, Magdalena Rosińska, Cristina Valente, Rui Tato Marinho, Odette Popovici, Mária Avdičová, Jana Kerlik, Irena Klavs, Mojca Maticic, Asuncion Diaz, Julia Del Amo, Josefine Lundberg Ederth, Maria Axelsson, Georgios Nikolopoulos
BACKGROUND: Epidemiological data are crucial to monitoring progress towards the 2030 Hepatitis C Virus (HCV) elimination targets. Our aim was to estimate the prevalence of chronic HCV infection (cHCV) in the European Union (EU)/European Economic Area (EEA) countries in 2019. METHODS: Multi-parameter evidence synthesis (MPES) was used to produce national estimates of cHCV defined as: π = πrec ρrec + πex ρex + πnon ρnon ; πrec , πex , and πnon represent cHCV prevalence among recent people who inject drugs (PWID), ex-PWID, and non-PWID, respectively, while ρrec , ρex , and ρnon represent the proportions of these groups in the population...
January 2024: The Lancet regional health. Europe